Tissue expression of inducible nitric oxide synthase requires IFN-γ production by infiltrating splenic T cells: More evidence for immunosuppression by nitric oxide

Journal of Neuroimmunology

Volumn 145, Issue 1-2, 2003, Pages 86-90

  Van Der Veen, Roel C ^a   Dietlin, Therese A ^a   Hofman, Florence M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

EAE; IFN ; NO; Spleen; T helper cells

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; EXPERIMENTAL MODEL; IMMUNIZATION; INFLAMMATION; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE; TISSUE; WILD TYPE;

EID: 0344009645     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.09.012     Document Type: Article

References (19)

1. Bogdan C. The multiplex function of nitric oxide in (auto)immunity. J. Exp. Med. 187:1998;1361-1365.
2. Cannella B., Gao Y.L., Brosnan C., Raine C.S. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;735-746.
3. Chu C.-Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon-γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:2000;123-128.
4. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1993;1739-1742.
5. Falcone M., Bloom B.R. A T helper 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:1998;901-907.
6. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
7. Juedes A.E., Ruddle N.H. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;5168-5175.
8. Kahn D.A., Archer D.C., Gold D.P., Kelly C.J. Adjuvant immunotherapy is dependent on inducible nitric oxide synthase. J. Exp. Med. 193:2001;1261-1267.
9. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
10. Lafaille J.J., Van de Keere F., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1996;307-312.
11. Pelaez B., Campillo J.A., Lopez-Asenjo J.A., Subiza J.L. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166:2001;6608-6615.
12. Sahrbacher U.C., Lechner F., Eugster H.P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1332-1338.
13. van der Veen R.C. Nitric oxide and T helper cell immunity (review). Int. Immunopharmacol. 1:2001;1491-1500.
14. van der Veen R.C., Hinton D.R., Incardonna F., Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1997;1-7.
15. van der Veen R.C., Dietlin T.A., Hofman F.M., Pen L., Segal B.H., Holland S.M. Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J. Immunol. 164:2000;5177-5183.
16. van der Veen R.C., Dietlin T.A., Pen L., Gray J.D., Hofman F.M. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-γ is essential but insufficient. Cell. Immunol. 206:2000;125-135.
17. Weishaupt A., Jander S., Bruck W., Kuhlmann T., Stienekemeier M., Hartung T., Toyka K.V., Stoll G., Gold R. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J. Immunol. 165:2000;7157-7163.
18. Willenborg D.O., Fordham S., Bernard C.C.A., Cowden W.B., Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
19. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., Cowden W.B. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163:1999;5278-5286.